
Three entries for review
Confirm the exact formulation, manufacturer, current regulatory status and package. The source does not identify Winstrol tablets.
Explore pharmacy listings
Review the stanozolol source entries with clear regulatory and product context. Confirm the exact preparation and current requirements; catalog inclusion is not proof of approval or availability.
Already approved? Sign in to see products and pricing for your practice.
Optimal lists 10 mg, 25 mg and 50 mg names without a dosage form or package. These are source specifications, not patient dosing instructions or confirmation of supply.
3 source entries. Open a pharmacy to review its listings. Repeated or similar names do not establish distinct products or current availability.
| Source preparation / review note | Listed strength / specification | Package |
|---|---|---|
| Stanozolol 10mgVerify exact product and current regulatory requirements | 10mg | Not specified — confirm |
| Stanozolol 25mgVerify exact product and current regulatory requirements | 25mg | Not specified — confirm |
| Stanozolol 50mgVerify exact product and current regulatory requirements | 50mg | Not specified — confirm |
Review the exact product with the responsible pharmacy before submitting an order.
Complete practice and account review to get started.
Review the preparation, pharmacy information and account pricing.
Confirm your cart, order details and applicable requirements.
Use saved carts and order history for repeat purchasing.
Participating pharmacies retain prescription review, dispensing and fulfillment responsibilities.
The treating clinician determines suitability and prescribing. Review the exact product’s labeling and pharmacy information.
Stanozolol is an anabolic steroid. The named source amounts do not identify a manufacturer, dosage form or approved product.
Winstrol 2 mg tablets were included in FDA’s 2010 notice withdrawing applications for products no longer marketed. That notice does not establish approval for the catalog’s different amounts or formulations. Product-specific safety, prescribing and current regulatory review remain essential. Published clinical research has reported stanozolol-associated liver injury. PubMed: stanozolol liver injury study FDA / Federal Register: Winstrol application withdrawal
Confirm the regulatory status of the exact preparation. Compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness or quality. FDA: compounded drug information
Sources checked October 19, 2026. This page provides product information, not diagnosis, treatment selection, dosing or administration instructions.
No. The source identifies stanozolol by amount but does not name Winstrol, a manufacturer or a dosage form. The historical reference product and these entries must not be treated as identical.
This page represents 3 source entries. Some names may overlap; confirm the exact product and current availability through your approved account.
No. Product amounts, concentrations and package quantities describe different specifications. The clinician and dispensing pharmacy determine the prescription and instructions.
Interchangeability is not established by a shared ingredient name, matching concentration or release abbreviation. Review each complete formulation and label.
No approval status is established by catalog inclusion. Compounded preparations are not FDA-approved. Confirm the exact product and regulatory status with the pharmacy.
Ordering and account pricing are available to verified, approved clinic accounts. Patients should discuss prescriptions and treatment with their clinician.
Review the current ingredient list, strength units, dosage form, route, release characteristics, package, availability, storage and applicable pharmacy requirements.
Email info@corelinkpharm.com for platform and account questions. Contact the pharmacy for product-specific information.
Start with account access. Keep product review, pricing and ordering together.